{
  "id": 6583829,
  "title": "PPARδ Expression and Prognosis in Resected Pancreatic Cancer: A Retrospective Single-Centre Study",
  "url": "https://urgent.news/2026/09/10/ppar-expression-and-prognosis-in-resected-pancreatic-cancer-a",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-10T00:00:00.000Z",
  "source": {
    "name": "bioRxiv",
    "slug": "biorxiv",
    "url": "https://www.biorxiv.org/content/10.64898/2026.09.08.750098v1?rss=1"
  },
  "original_language": "en",
  "account": "Pancreatic cancer is an extremely deadly form of cancer with few curative options and poor long-term outcomes. Recent research has focused on the role of nuclear receptors, such as PPAR{delta}, in tumor progression. In a recent study, researchers retrospectively examined 25 resected pancreatic cancer specimens from patients who underwent Whipple's procedure (pancreatoduodenectomy) between 2000 and 2009. Immunohistochemistry was performed to detect PPAR{delta} expression in the tumors and stromal tissues. The results showed that PPAR{delta} was expressed in the majority of the samples analyzed.\n\nThe researchers then correlated the PPAR{delta} expression with clinicopathological features and survival data of the patients. Their preliminary findings suggest that higher levels of PPAR{delta} expression are associated with more aggressive tumor biology and poorer survival rates in pancreatic cancer patients. This study's findings indicate that PPAR{delta} immunohistochemistry could potentially identify a subset of pancreatic cancers with more aggressive characteristics. However, the researchers emphasize that further, larger studies are necessary to validate these findings and determine the clinical significance of PPAR{delta} expression in pancreatic cancer prognosis.",
  "summary": "Background: Pancreatic cancer remains one of the most lethal malignancies, with limited curative options and poor long-term outcomes. Nuclear receptors, including PPAR{delta}, have been implicated in tumour progression. Methods: Retrospectively, we analysed 25 resected pancreatic cancer specimens from patients undergoing Whipple!s procedure (pancreatoduodenectomy) between 2000 and 2009.…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}